Table 1 Antimicrobial activity of compounds (a1–a3)
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Zone of inhibition (in mm) | |||||
|---|---|---|---|---|---|---|
Microbial species | ||||||
B. subtilis | B. pumilis | E. coli | P. vulgaris | A. niger | P. crysogenium | |
a1 | ||||||
 A | 15 | 12 | 11 | 12 | 11 | 12 |
 B | 20 | 14 | 20 | 18 | 13 | 14 |
a2 | ||||||
 A | 16 | 13 | 12 | 15 | 16 | 15 |
 B | 20 | 15 | 21 | 21 | 18 | 18 |
a3 | ||||||
 A | 17 | 14 | 13 | 14 | 15 | 14 |
 B | 20 | 15 | 21 | 20 | 17 | 17 |
C | – | – | – | – | – | – |
S | ||||||
 A | 25 | 29 | 26 | 28 | 23 | 24 |
 B | 30 | 31 | 29 | 31 | 28 | 27 |